Clinical trials
Active, not recruiting Phase 2 Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 9 |
| 2016 | 14 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 3 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 60 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 33 |
| M.D. Anderson Cancer Center | 4 |
| Center for International Blood and Marrow Transplant Research | 2 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
| BeiGene | 1 |
| Canadian Cancer Trials Group | 1 |
| Celgene | 1 |
| Cellectar Biosciences, Inc. | 1 |
| City of Hope Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 60 |
| Multiple Myeloma | 34 |
| Hematologic Neoplasms | 18 |
| Leukemia | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Hematologic Diseases | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma, Mantle-Cell | 4 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.